[Experience using sinakten-retard in the treatment of muscular sclerosis]
- PMID: 207061
[Experience using sinakten-retard in the treatment of muscular sclerosis]
Abstract
The experience of the authors demonstrated that the best results in sinakten-retard treatment were attained in patients with mild and moderate degrees of severity of the disease. However, even in patients with a protracted development, treatment by sinakten-retard increased the muscular strength in the paralyzed extremities, diminished the increased muscular tone and increased the volume of movements. All these facts permit the authors to recommend sinakten-retard for the treatment of disseminated sclerosis.